Pancreatic Insufficiency Terminated Phase 1 / 2 Trials for Pancrelipase amylase (DB11065)

Also known as: Pancreatic failure / Pancreatic insufficiency (disorder) / Insufficiency pancreatic / Exocrine pancreatic insufficiency / Pancreatic exocrine insufficiency / Exocrine pancreatic insufficiency (disorder)

IndicationStatusPhase
DBCOND0031191 (Pancreatic Insufficiency)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02985801PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic CancerTreatment